Resveratrol-Copper Supplements Show Promise Against Glioblastoma in India Study
A pilot study from India found that a combination of resveratrol and copper supplements reduced markers of aggressiveness in glioblastoma brain tumors by approximately 33% without side effects. This early research suggests a potential new, low-cost approach to brain cancer treatment.
- Pilot study used resveratrol and copper supplements for glioblastoma.
- Reduced tumor aggressiveness marker Ki-67 by nearly one-third.
- Study conducted on 20 glioblastoma patients in Mumbai, India.
- No notable side effects reported in treated patients.
- Focuses on 'healing' tumors by neutralizing harmful DNA fragments.
- Findings are preliminary, requiring larger scale human trials.
Read the full story on Quick Digest.